Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

No reported Accounts Payables figures are available to summarize.

Accounts Payables history

Currency unavailable · from the cash flow

No Accounts Payables data reported for this period type.

Accounts Payables vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Accounts Payables for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ANABAnaptysBio, Inc.LTM Mar 2026$81.11M USD+53.9%—34.9%
ORKAOruka Therapeutics, Inc.LTM Sep 2026$12.17M USD+5581.5%——
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$8.3M USD+286.2%+184.2%99.2%
IMUXImmunic, Inc.LTM Mar 2026$4.41M USD+702.6%+15.7%—
ALMSAlumis Inc. Common StockLTM Jun 2026$2.18M USD+391.0%—29.5%
SYRESpyre Therapeutics, Inc.LTM Sep 2026$1.46M USD+112.4%—1.6%
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$214K USD+223.7%+22.1%0.1%
ODTXOdyssey Therapeutics, Inc.—— ———
AGMBAgomAb Therapeutics N.V. American Depositary Shares—— ———
Peer median (excluding ODTX) —+286.2%+22.1%29.5%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.